Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan and tadalafil fixed-dose combination versus monotherapies in pulmonary arterial hypertension
jRCT2080224886Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of macitentan + tadalafil in pulmonary arterial hypertension (PAH) (3 arms), sponsored by Janssen Pharmaceutical. Started Sep 2019; status: completed.
02
Drugs
macitentan + tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT2080224886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224886.